FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX

MDR report key: 2160561 · Received July 6, 2011

Report

Report Number
9612164-2011-00675
Event Type
Injury
Date Received
July 6, 2011
Date of Event
March 31, 2014
Report Date
September 9, 2014
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). RESULTS: (MYOCARDIAL INFARCTION).

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

IT IS REPORTED THAT APPROXIMATELY 34 MONTHS POST INDEX PROCEDURE, THE PATIENT UNDERWENT RE-PTCA OF THE TARGET LESION. IT IS REPORTED THAT THE PATIENT WAS TREATED WITH OTHER DES. THE OUTCOME IS REPORTED AS SUCCESSFUL.

Description of Event or Problem · 1

APPROXIMATELY 19 MONTHS POST INDEX PROCEDURE THE PATIENT SUFFERED AN MI. IT IS UNKNOWN WHETHER THE REPORTED MI WAS RELATED TO THE TARGET VESSEL. THE INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE DEVICE.

Description of Event or Problem · 1

IT IS REPORTED THAT INVESTIGATOR ASSESSED THAT THE REVASCULARIZATION THAT WAS CARRIED OUT 34 MONTHS POST INDEX PROCEDURE TO BE DEFINITELY RELATED TO THE STUDY DEVICE.

Description of Event or Problem · 1

DURING INDEX PROCEDURE, THE PATIENT HAD ONE ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG-ELUTING STENT IMPLANTED TO THE PROX LAD. THE DAY AFTER THE INDEX PROCEDURE, IT IS REPORTED THAT A MI OCCURRED. IT IS UNKNOWN WHETHER THE REPORTED MI IS RELATED TO THE TARGET VESSEL. THE INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS POSSIBLY RELATED TO THE STUDY DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND NA 0002379220

Patients

Seq Age Sex Outcome Treatment
1 48 YR Hospitalization| R ASA AND| PATIENT WAS TAKING BETA-BLOCKERS| LIPID LOWERING DRUG| NITRATE| CLOPIDOGREL AT TIME OF EVENT